Halting Ornithine Transcarbamylase Deficiency With Recombinant AAV in ChildrEn | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Halting Ornithine Transcarbamylase Deficiency With Recombinant AAV in ChildrEn	Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, X-linked disease, brain disorder, central nervous system disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, nervous system disorder, ornithine carbamoyltransferase deficiency, urea cycle disorder	Recruiting	Phase 1 / Phase 2	2023-11-07		NCT05092685

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University College, London	222

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Great Ormond Street Hospital	London	United Kingdom	38